I would like to know why Professor Raoult’s protocol is not tested stricto sensu in the Discovery trial?
As a reminder, the Raoult protocol is: hydroxychloroquine (200 mg x 3 per day for 10 days) + Azithromycin (500 mg on the 1st day then 250 mg per day for 5 more days)
the Raoult protocol made so much noise that the state was obliged to include it in its European discovery trial ….. but not its protocol
Didier Raoult (born March 13, 1952 in Dakar, Senegal)  is a French physician and microbiologist. He holds M.D. and Ph.D. degrees and specializes in infectious diseases. In 1984, Raoult created the Rickettsia Unit at Aix-Marseille University (AMU). He also teaches infectious diseases in the Faculty of Medicine of Aix-Marseille University, and since 1982 has supervised many M.D. and Ph.D. degrees. 
It is the only molecule which is no longer under patent of the protocol so they do not want it, but since it made a fuss, to calm everyone, they include chloroquine in the European test but not following the right protocol like that it will not work and they can say: well here you see we listened to you
Like that everyone happy.
They could not think that like you we are a lot because we are informed to have understood that the purpose of including chloroquine in the test is to discredit it.
It is exactly the same for the chloroquine restriction decree which authorizes its use for severe cases (by our French government) where the Raoult protocol highlights the low efficacy of chloroquine in severe cases!
there are over 30 clinical trials registered on clinicaltrialsdotgov right now for hydroxychloroquine. not just treating covid-19 infected but prophylactic treatment of health care professionals treating covid-19 patients. so doesn’t mean they are ethics approved. but wow.
Meanwhile, 3 big names in health-management in France support Raoult …
Dominique Maraninchi, Fabien Calvo and Jean-Luc Harousseau, former directors and presidents of the ANSM, the HAS and the INCA.
But they are saying Hydroxychloroquine-COVID-19 study did not meet publishing society’s “expected standard”: